Tag Archives: Pfizer

Coronavirus Vaccine: Pfizer Says It Won’t Seek Authorization Before Mid-November

The chief executive of Pfizer said on Friday that the company would not apply for emergency authorization of its coronavirus vaccine before the third week of November, ruling out President Trump’s assertion that a vaccine would be ready before Election Day on Nov. 3. In a statement posted to the company website, the chief executive,… Read More »

Pfizer, Novartis and more halt July ads on Facebook to protest hate and racism

Pharma companies including Pfizer, Novartis and AbbVie have paused advertising on Facebook for July. Their brands join others in the Stop Hate for Profit campaign, meant to pressure Facebook into taking action against hate and disinformation spread on its platform. Pfizer is the largest of the pharma companies participating and one of three overall top 25… Read More »

Pfizer challenges Roche blockbusters with 3 biosim launches at discounts from 22% to 24%

Pfizer hit some unexpected roadblocks with its first U.S. biosimilar launch, but it’s not giving up in the budding field. Now, the drugmaker is launching biosims to three Roche cancer blockbusters at discounts ranging from 22% to 24%.   The company has already rolled out Zirabev and Ruxience, its biosimilars to Roche’s Avastin and Rituxan, respectively, at discounts of 23% and 24%. On… Read More »